Kelly P J
Department of Neurosurgery, Mayo Clinic, Rochester, Minn.
Stereotact Funct Neurosurg. 1992;59(1-4):84-91. doi: 10.1159/000098922.
With imaging-based volumetric stereotactic techniques, it is possible to selectively and accurately remove any CT- or MRI-defined part or all of any intra-axial neoplasm. However, glial neoplasms are composed of two elements: tumor tissue and isolated tumor cells which infiltrate brain parenchyma. In high-grade gliomas and pilocytic astrocytomas, the tumor tissue component is most accurately defined by the volume of contrast enhancement. Tumor tissue in low-grade nonpilocytic gliomas is indistinguishable on imaging from infiltrated parenchyma. Stereotactic biopsy is presently the only method by which CT hypodense tumor tissue can be differentiated from infiltrated parenchyma, which is also hypodense. In eloquent brain areas, stereotactic resection is appropriate for the tumor tissue component only in patients harboring glial tumors.
采用基于成像的容积立体定向技术,能够选择性且准确地切除任何由CT或MRI界定的轴内肿瘤的部分或全部。然而,神经胶质瘤由两种成分组成:肿瘤组织和浸润脑实质的孤立肿瘤细胞。在高级别胶质瘤和毛细胞型星形细胞瘤中,肿瘤组织成分最准确的界定是对比增强的体积。在影像学上,低级别非毛细胞型胶质瘤中的肿瘤组织与浸润的实质难以区分。立体定向活检是目前唯一能将CT低密度的肿瘤组织与同样呈低密度的浸润实质区分开来的方法。在脑功能区,对于患有神经胶质瘤的患者,立体定向切除术仅适用于肿瘤组织成分。